Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
SwedenIPO:
26 March 2021Website:
http://www.olink.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/ADividend
Analysts recommendations
Institutional Ownership
Included in screeners
Similar companies
OLK Latest News
Olink's (OLK) buyout by Thermo Fisher gets CMA's approval, signaling regulatory confidence in the merger's compliance with competition laws.
Olink Holding AB (publ) Sponsored ADR (OLK) reported a quarterly loss of $0.13 per share, slightly higher than the expected loss of $0.12 per share according to the Zacks Consensus Estimate. This is compared to a loss of $0.11 per share in the same quarter last year.
Quantum-Si has a ton of promise if the proteomics market continues to develop. Thermo Fisher indicated the future potential with its big pending acquisition of Olink.
Thermo Fisher Scientific plans to acquire Olink for $3.1 billion. The deal would add Olink's proteomics technology to Thermo Fisher's life sciences solutions.
Olink Holding AB (publ) (NASDAQ:OLK ) Q2 2023 Earnings Conference Call August 9, 2023 8:00 AM ET Company Participants Jan Medina - VP, IR & Capital Markets Jon Heimer - CEO & Director Carl Raimond - President Oskar Hjelm - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Puneet Souda - Leerink Partners Sung Ji Nam - Scotiabank Matthew Sykes - Goldman Sachs Group Yuko Oku - Morgan Stanley Operator Good day, and thank you for standing by. Welcome to the Olink Proteomics Q2 2023 Earnings Conference Call.
The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in Olink Holding AB (publ) Sponsored ADR (OLK). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Olink Holding AB (publ) (NASDAQ:OLK ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Jan Medina - Vice President of Investor Relations and Capital Markets Jon Heimer - Chief Executive Officer Carl Raimond - President Oskar Hjelm - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink Sung Ji Nam - Scotiabank Kyle Mikson - Canaccord Genuity Ivy Kozlowski - Goldman Sachs Operator Good morning, and thank you for standing by. Welcome to the Olink Proteomics Fourth Quarter 2022 Earnings Conference Call.
Olink Holding AB (publ) Sponsored ADR (OLK) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.10 per share a year ago.
Olink Holding AB (publ) Sponsored ADR (OLK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What type of business is Olink Holding AB (publ)?
Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden. As of July 10, 2024, Olink Holding AB (publ) operates as a subsidiary of Thermo Fisher Scientific Inc..
What sector is Olink Holding AB (publ) in?
Olink Holding AB (publ) is in the Healthcare sector
What industry is Olink Holding AB (publ) in?
Olink Holding AB (publ) is in the Diagnostics & Research industry
What country is Olink Holding AB (publ) from?
Olink Holding AB (publ) is headquartered in Sweden
When did Olink Holding AB (publ) go public?
Olink Holding AB (publ) initial public offering (IPO) was on 26 March 2021
What is Olink Holding AB (publ) website?
https://www.olink.com
Is Olink Holding AB (publ) in the S&P 500?
No, Olink Holding AB (publ) is not included in the S&P 500 index
Is Olink Holding AB (publ) in the NASDAQ 100?
No, Olink Holding AB (publ) is not included in the NASDAQ 100 index
Is Olink Holding AB (publ) in the Dow Jones?
No, Olink Holding AB (publ) is not included in the Dow Jones index
When was Olink Holding AB (publ) the previous earnings report?
No data
When does Olink Holding AB (publ) earnings report?
Next earnings report date is not announced yet